Inactive Instrument
LAVA Therapeutics Stock
Stocks
LVTX
NL0015000AG6
Biotechnology & Medical Research
| 1 day | -3.87% |
| 1 year | 1.44 |  | 1.82 |
| 3 years | 0.85 | | 6.47 |
| 5 years | 0.85 | | 8 |
| 10 years | 0.85 | | 17.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 2021-11-08 | |
Robin Hume
LAW | General Counsel | - | 2023-05-14 |
| Human Resources Officer | - | 2021-11-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Kapil Dhingra
CHM | Chairman | 66 | 2021-02-21 |
Karen Wilson
BRD | Director/Board Member | 63 | 2021-02-28 |
Owen Hughes
BRD | Director/Board Member | 51 | 2025-11-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/13/25 | Issuer sale | Chief Executive Officer | 340,100 | 1.2929% | ||
| 11/13/25 | Issuer sale | Chief Financial Officer | 189,700 | 0.7211% | ||
| 11/13/25 | Issuer sale | Director | 33,390 | 0.1269% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87% | -.--% | - | - | 45.77M | |
| -4.10% | -8.54% | +40.05% | +66.99% | 66.22B | |
| -0.41% | +3.27% | +10.46% | +72.82% | 55.2B | |
| +0.74% | +4.04% | +12.18% | +88.71% | 52.79B | |
| +0.61% | +2.69% | +27.75% | +50.97% | 45.53B | |
| -1.08% | +2.19% | +21.92% | +131.38% | 43.94B | |
| -3.39% | -0.83% | +254.27% | +571.04% | 41.64B | |
| -1.67% | +6.70% | +14.42% | +56.67% | 34B | |
| -3.84% | -9.34% | +23.10% | -5.31% | 25.84B | |
| +1.30% | +6.97% | +38.37% | +28.59% | 23.51B | |
| Average | -1.53% | +1.06% | +49.17% | +117.98% | 43.19B | |
| Weighted average by Cap. | -1.37% | +0.84% | +48.05% | +122.14% |
Employees
10
